Tandem Diabetes Care (TNDM) Change in Intangibles (2013 - 2020)
Tandem Diabetes Care posted quarterly Change in Intangibles of $81000.0 for Q3 2020, up 9.46% on a QoQ basis from $74000.0 in Q1 2015.
Tandem Diabetes Care (TNDM) has 4 years of Change in Intangibles data on file, last reported at $81000.0 in Q3 2020.
- For the quarter ending Q3 2020, Change in Intangibles changed N/A year-over-year to $81000.0; the trailing twelve-month figure through Sep 2021 stood at $81000.0 (changed 0.0% YoY), and the FY2020 full-year result was $4.9 million, changed N/A from the prior year.
- Change in Intangibles for Q3 2020 stood at $81000.0, up from $74000.0 in the prior quarter.
- Across five years, Change in Intangibles topped out at $81000.0 in Q3 2020 and bottomed at $81000.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -31.61 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 81,000.00 |
| Sep 30, 2020 | 81,000.00 |
| Mar 31, 2015 | 74,000.00 |
| Mar 31, 2015 | 74,000.00 |
| Mar 31, 2014 | 173,000.00 |
| Mar 31, 2014 | 173,000.00 |
| Sep 30, 2013 | 1.50 Mn |
| Sep 30, 2013 | 1.50 Mn |
| Mar 31, 2013 | 500,000.00 |
| Mar 31, 2013 | 500,000.00 |